Rapid Micro Biosystems shares surge 20.07% intraday following 37% Q4 revenue growth to $11.3 million.

Rapid Micro Biosystems surged 20.07% intraday following a report of 37% revenue growth in Q4 2025, with the company expecting $11.3 million in total revenue for the quarter. The announcement highlights strong performance in its core operations, likely driving investor optimism about the firm’s financial health and future prospects.